Hologic (HOLX) Tops Q1 EPS by 95c; Raises Guidance Sharply

Hologic (NASDAQ: HOLX) reported Q1 EPS of $2.17, $0.95 better than the analyst estimate of $1.22. Revenue for the quarter came in at $1.47 billion versus the consensus estimate of $1.13 billion.

GUIDANCE:

Hologic sees FY2022 EPS of $4.90-$5.20, versus the consensus of $3.83. Hologic sees FY2022 revenue of $4.4-4.55 billion, versus the consensus of $4.02 billion.

For earnings history and earnings-related data on Hologic (HOLX) click here.

You May Also Be Interested In

• Toll Brothers (TOL) Tops Q3 EPS by 5c, reaffirms guidance
• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• Taylor Devices (TAYD) Misses Q4 EPS by 31c